到 2030 年口腔炎治療市場預測：按類型、藥物類別、劑型、適應症、給藥途徑、給藥配銷通路、最終用戶和地區進行的全球分析

根據 Stratistics MRC 的數據，2023 年全球口腔炎治療市場規模將達到 15.9 億美元，預計 2030 年將達到 23.7 億美元，預測期內複合年成長率為 5.9%。

口腔潰瘍，通常稱為潰瘍，是出現在舌頭、臉頰內側和嘴唇上的令人難以忍受的潰瘍。口腔潰瘍通常會在 1 至 2 週內自行癒合，但有一些治療方法可以減輕不適並加速癒合。含有苯佐卡因或水楊酸膽鹼的非處方外用軟膏或凝膠也可以緩解疼痛。用鹽水漱口也可能有助於減少發炎和促進癒合。

根據世界衛生組織2020年報告，2020年全球約22.30%的人口消費菸草製品，全球80%以上的菸草使用者生活在低收入和中等收入國家。使用菸草會導致口腔潰瘍，進而增加對治療產品的需求。

增加知識和獲得醫療保健的機會

在教育宣傳活動和資訊普及的支持下，人們對口腔健康的認知不斷提高，從而改變了對口腔健康問題（如口腔潰瘍）及時就醫的態度。在實體基礎設施和遠端醫療選擇方面改善醫療保健服務的可近性，增加了快速解決口腔健康問題的可能性。

缺乏標準化治療指南

口腔炎的治療指引尚未標準化或廣泛接受，增加了醫療治療的變異性。不同的臨床醫生可能採取不同的方法，因此很難建立標準化的治療方案。此外，標準化的缺乏使得該行業難以提供簡潔且有科學支持的口腔潰瘍治療方案。

全面的牙齒健康成為日益重要的優先事項

隨著人們越來越意識到口腔健康與整體健康之間的聯繫，口腔潰瘍治療市場有機會在整體口腔清潔用品的大背景下立足。此外，將預防措施、飲食建議和生活方式提案涵蓋治療計劃可以利用這一趨勢並促進更徹底的以患者為中心的方法。

經濟衰退與經濟承受能力問題

經濟不穩定和景氣衰退可能會影響消費者在醫療用品（例如口腔潰瘍藥物）上的金額。經濟困難可能會導致人們選擇更便宜的選擇或推遲接受幫助。此外，市場參與企業將檢查定價策略、患者援助計劃和市場進入工作，以確保在經濟不確定時期持續可及，從而減輕經濟挑戰的影響。您應該這樣做。

COVID-19 的影響：

由於製造、供應鏈和醫療保健的中斷，COVID-19 大大流行對口腔炎治療市場產生了重大影響。由於封鎖、社交距離措施以及與疫情相關的醫療保健優先事項增加，導致常規醫療就診次數減少，口腔潰瘍的診斷和治療受到影響。此外，該市場的收益流也可能受到消費行為變化和影響購買模式的經濟不確定性的影響。

預計抗生素市場在預測期內將是最大的市場

市場佔有率最大的細分市場是抗菌劑細分市場。抗菌藥物（例如局部抗生素和防腐劑）對於口腔潰瘍的治療至關重要，因為它們能夠預防或治療細菌和微生物感染。這些治療方法因其集中治療口腔潰瘍的感染性方面、促進癒合和減少相關症狀而經常被推廣。此外，抗菌領域有多種局部製劑，如凝膠、軟膏和漱口水，為醫療保健專業人員和消費者提供了多種有效治療口腔潰瘍的選擇。

家庭護理產業預計在預測期內複合年成長率最高

在口腔炎治療市場中，家庭護理領域的複合年成長率最高。這一成長的推動因素包括在家中使用非處方口腔潰瘍藥物的便利性、自行用藥的日益普及以及支持遠距諮詢的遠端醫療服務的發展。此外，口腔保健意識的提高和技術進步使人們無需等待緊急臨床干預即可獲得治療口腔炎的資訊和產品，這是向居家照護轉變的主要驅動力。這是一個促成因素。

比例最高的地區：

在口腔炎治療市場中，亞太地區佔最大的市場佔有率。許多因素促成了該地區的這一優勢，包括口腔潰瘍的高發病率、高齡化、口腔衛生意識的提高以及製藥公司為擴大在新興市場的足跡而做出的不懈努力。此外，亞太地區多樣化的醫療保健格局、可支配收入的增加以及醫療基礎設施的改善也促進了口腔炎治療市場的強勁成長。

複合年成長率最高的地區：

在口腔炎治療市場中，北美目前顯示出最高的複合年成長率。強大的醫療基礎設施、高昂的醫療成本以及對研發的重視正在推動該地區的強勁成長。該地區的高齡化、口腔潰瘍發生頻率的增加以及口腔健康意識的提高，都推動了對尖端、高效治療方案的需求不斷成長。此外，由於行業巨頭的存在、技術進步和積極主動的醫療保健管理方法，北美市場正在擴大。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

• 公司簡介
  • 其他市場公司的綜合分析（最多 3 家公司）
  • 主要企業SWOT分析（最多3家企業）
• 區域分割
  • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

• 概述
• 相關利益者
• 調查範圍
• 調查方法
  • 資料探勘
  • 資料分析
  • 資料檢驗
  • 研究途徑
• 調查來源
  • 主要調查來源
  • 二次調查來源
  • 先決條件

第3章市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 最終用戶分析
• 新興市場
• 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

• 供應商的議價能力
• 買方議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第5章全球口腔炎治療市場：依類型

• 次要的
• 選拔科目
• 皰疹性的
• 其他類型

第6章全球口腔炎治療市場：依藥物類別

• 抗菌的
• 抗組織胺藥
• 止痛藥
• 皮質類固醇
• 其他藥物類別

第7章全球口腔炎治療市場：按劑型

• 噴
• 漱口水
• 凝膠
• 菱形
• 其他劑型

第8章全球口腔炎治療市場：依適應症分類

• 口瘡性口炎
• 口腔扁平苔癬
• 其他適應症

第9章全球口腔炎治療市場：依給藥途徑

• 口服
• 局部的

第10章全球口腔炎治療市場：依配銷通路

• 醫院藥房
• 零售藥房
• 網路藥房

第11章全球口腔炎治療市場：依最終使用者分類

• 居家護理
• 診所
• 醫院
• 其他最終用戶

第12章全球口腔炎治療市場：按地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東/非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東/非洲

第13章 主要進展

• 合約、夥伴關係、協作和合資企業
• 收購和合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第14章 公司簡介

• Celgene Corporation
• 3M Company
• GSK plc
• Colgate-Palmolive Company
• Blairex Laboratories, Inc.
• Dr. Reddy's Laboratories
• Dental Herb Company
• Bristol-Myers Squibb Company
• GlaxoSmithKline, Plc
• Patterson Companies, Inc.
• Pfizer, Inc.
• Akorn Pharmaceuticals
• Church & Dwight Co, Inc.
• Prince Care Pharma Private Limited
• Blistex Inc.
• Sun Pharmaceutical Jsc

According to Stratistics MRC, the Global Mouth Ulcer Treatment Market is accounted for $1.59 billion in 2023 and is expected to reach $2.37 billion by 2030 growing at a CAGR of 5.9% during the forecast period. Mouth ulcers, commonly referred to as canker sores, are excruciating sores that may appear on the tongue, inside the cheeks, or on the lips. Although they usually go away on their own in a week or two, there are treatments that can help reduce discomfort and encourage quicker healing. Moreover, benzocaine or choline salicylate-containing over-the-counter topical ointments or gels can relieve pain. It might also be beneficial to rinse the mouth with a saltwater solution to lessen inflammation and encourage healing.

According to WHO 2020 report, in 2020, approximately 22.30% of the global population consumed tobacco products, and over 80% of the world's tobacco users live in low- and middle-income countries. Tobacco use can lead to mouth ulcers and thus the demand for treatment products increases.

Market Dynamics:

Driver:

Increasing knowledge and access to healthcare

An attitude shift toward seeking prompt medical attention for oral health issues, such as mouth ulcers, has resulted from increased awareness of oral health, which has been supported by educational campaigns and information dissemination. Individuals are more likely to address oral health concerns promptly when there is improved access to healthcare services, both in terms of physical infrastructure and telehealth options.

Restraint:

Absence of standardized guidelines for treatment

The lack of standardized and widely accepted treatment guidelines for mouth ulcers adds to the variation in medical procedures. Different approaches may be taken by clinicians, which make it difficult to establish standardized treatment protocols. Furthermore, this lack of standardization may make it more difficult for the industry to offer concise, scientifically supported mouth ulcer treatment options.

Opportunity:

Growing priority for comprehensive dental health

The market for mouth ulcer treatments has a chance to establish itself within the larger context of holistic oral care as people become more conscious of the link between oral health and general well-being. Moreover, preventive measures, dietary advice, and lifestyle suggestions can be incorporated into treatment plans to take advantage of this trend and promote a more thorough and patient-centered approach.

Threat:

Economic downturn and problems with affordability

Financial instability and economic downturns can affect how much consumers spend on medical supplies, such as mouth ulcer remedies. Financial difficulties can lead people to choose less expensive options or put off getting help. Additionally, market participants should investigate pricing strategies, patient assistance programs, and market access initiatives to ensure continued accessibility during times of economic instability in order to lessen the impact of economic challenges.

COVID-19 Impact:

Due to disruptions in manufacturing, supply chains, and healthcare access, the COVID-19 pandemic has had a major effect on the market for mouth ulcer treatments. The diagnosis and treatment of mouth ulcers have been impacted by the decline in routine healthcare visits brought on by lockdowns, social distancing measures, and the increased healthcare priorities associated with the pandemic. Furthermore, the market's revenue streams may also be impacted by changes in consumer behaviour and economic uncertainty, which have an impact on buying patterns.

The Antimicrobial segment is expected to be the largest during the forecast period

The segment with the largest market share is the antimicrobial segment, due to their ability to prevent or treat bacterial and microbial infections, antimicrobial agents-such as topical antibiotics and antiseptics-are essential in the management of mouth ulcers. Due to their focused approach to treating the infectious aspect of mouth ulcers, accelerating healing, and reducing related symptoms, these treatments are frequently encouraged. Moreover, healthcare practitioners and consumers have a variety of options for effectively managing mouth ulcers thanks to the antimicrobial segment's wide range of topical formulations, which include gels, ointments, and mouthwashes.

The Homecare segment is expected to have the highest CAGR during the forecast period

In the mouth ulcer treatment market, the homecare segment is growing at the highest CAGR. The convenience of using over-the-counter mouth ulcer treatments at home, the growing popularity of self-administered treatments, and the development of telehealth services that enable remote consultations are some of the factors contributing to this growth. Additionally, growing awareness of oral health management and technological advancements that make it possible for people to obtain information and products for treating mouth ulcers without waiting for urgent clinical intervention are the main drivers of the shift towards homecare.

Region with largest share:

In the mouth ulcer treatment market, the Asia-Pacific area holds the largest market share. Numerous factors contribute to this dominance, such as the high frequency of mouth ulcers in the area, an aging population, rising oral health awareness, and pharmaceutical companies' persistent efforts to increase their footprint in emerging markets. Furthermore, the diverse healthcare landscape of the Asia-Pacific region, along with rising disposable incomes and improved healthcare infrastructure, has also contributed to the market's robust growth for mouth ulcer treatments.

Region with highest CAGR:

In the mouth ulcer treatment market, North America is currently showing the highest CAGR. A strong healthcare infrastructure, high healthcare spending, and a strong emphasis on research and development are some of the factors driving the region's robust growth. The aging population in the area, the increasing frequency of mouth ulcers, and the increased focus on oral health all add to the rising need for cutting-edge and efficient treatment options. Moreover, the market is expanding in North America due in part to the presence of major players in the industry, technological advancements, and a proactive approach to healthcare management.

Key players in the market:

Some of the key players in Mouth Ulcer Treatment market include Celgene Corporation, 3M Company, GSK plc, Colgate-Palmolive Company, Blairex Laboratories, Inc., Dr. Reddy's Laboratories, Dental Herb Company, Bristol-Myers Squibb Company, GlaxoSmithKline, Plc, Patterson Companies, Inc., Pfizer, Inc., Akorn Pharmaceuticals, Church & Dwight Co, Inc., Prince Care Pharma Private Limited, Blistex Inc. and Sun Pharmaceutical Jsc.

Key Developments:

In December 2023, Dr Reddy's Laboratories on Wednesday said its unit has inked a licensing agreement with Coya Therapeutics Inc to develop a combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Dr Reddy's Laboratories SA and Coya have entered into a development and license agreement for the development and commercialisation of COYA 302, an investigational combination therapy for ALS, the Hyderabad-based drugmaker said in a statement.

In November 2023, GSK plc and Arrowhead Pharmaceuticals Inc. have announced that they have reached an agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, to transfer exclusive worldwide rights to further develop and commercialise JNJ-3989 to GSK. JNJ-3989 (formerly ARO-HBV) was initially in-licensed by Janssen from Arrowhead in 2018.

In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

Types Covered:

• Minor
• Major
• Herpetiform
• Other Types

Drug Classes Covered:

• Antimicrobial
• Antihistamine
• Analgesics
• Corticosteroids
• Other Drug Classes

Formulations Covered:

• Sprays
• Mouthwash
• Gels
• Lozenges
• Other Formulations

Indications Covered:

• Aphthous Stomatitis
• Oral Lichen Planus
• Other Indications

Route of Administrations Covered:

• Oral
• Topical

Distribution Channels Covered:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

End Users Covered:

• Homecare
• Clinic
• Hospital
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Mouth Ulcer Treatment Market, By Type

• 5.1 Introduction
• 5.2 Minor
• 5.3 Major
• 5.4 Herpetiform
• 5.5 Other Types

6 Global Mouth Ulcer Treatment Market, By Drug Class

• 6.1 Introduction
• 6.2 Antimicrobial
• 6.3 Antihistamine
• 6.4 Analgesics
• 6.5 Corticosteroids
• 6.6 Other Drug Classes

7 Global Mouth Ulcer Treatment Market, By Formulation

• 7.1 Introduction
• 7.2 Sprays
• 7.3 Mouthwash
• 7.4 Gels
• 7.5 Lozenges
• 7.6 Other Formulations

8 Global Mouth Ulcer Treatment Market, By Indication

• 8.1 Introduction
• 8.2 Aphthous Stomatitis
• 8.3 Oral Lichen Planus
• 8.4 Other Indications

9 Global Mouth Ulcer Treatment Market, By Route of Administration

• 9.1 Introduction
• 9.2 Oral
• 9.3 Topical

10 Global Mouth Ulcer Treatment Market, By Distribution Channel

• 10.1 Introduction
• 10.2 Hospital Pharmacy
• 10.3 Retail Pharmacy
• 10.4 Online Pharmacy

11 Global Mouth Ulcer Treatment Market, By End User

• 11.1 Introduction
• 11.2 Homecare
• 11.3 Clinic
• 11.4 Hospital
• 11.5 Other End Users

12 Global Mouth Ulcer Treatment Market, By Geography

• 12.1 Introduction
• 12.2 North America
  • 12.2.1 US
  • 12.2.2 Canada
  • 12.2.3 Mexico
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 Italy
  • 12.3.4 France
  • 12.3.5 Spain
  • 12.3.6 Rest of Europe
• 12.4 Asia Pacific
  • 12.4.1 Japan
  • 12.4.2 China
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 New Zealand
  • 12.4.6 South Korea
  • 12.4.7 Rest of Asia Pacific
• 12.5 South America
  • 12.5.1 Argentina
  • 12.5.2 Brazil
  • 12.5.3 Chile
  • 12.5.4 Rest of South America
• 12.6 Middle East & Africa
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 Qatar
  • 12.6.4 South Africa
  • 12.6.5 Rest of Middle East & Africa

13 Key Developments

• 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 13.2 Acquisitions & Mergers
• 13.3 New Product Launch
• 13.4 Expansions
• 13.5 Other Key Strategies

14 Company Profiling

• 14.1 Celgene Corporation
• 14.2 3M Company
• 14.3 GSK plc
• 14.4 Colgate-Palmolive Company
• 14.5 Blairex Laboratories, Inc.
• 14.6 Dr. Reddy's Laboratories
• 14.7 Dental Herb Company
• 14.8 Bristol-Myers Squibb Company
• 14.9 GlaxoSmithKline, Plc
• 14.10 Patterson Companies, Inc.
• 14.11 Pfizer, Inc.
• 14.12 Akorn Pharmaceuticals
• 14.13 Church & Dwight Co, Inc.
• 14.14 Prince Care Pharma Private Limited
• 14.15 Blistex Inc.
• 14.16 Sun Pharmaceutical Jsc

List of Tables

• Table 1 Global Mouth Ulcer Treatment Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Mouth Ulcer Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Mouth Ulcer Treatment Market Outlook, By Minor (2021-2030) ($MN)
• Table 4 Global Mouth Ulcer Treatment Market Outlook, By Major (2021-2030) ($MN)
• Table 5 Global Mouth Ulcer Treatment Market Outlook, By Herpetiform (2021-2030) ($MN)
• Table 6 Global Mouth Ulcer Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 7 Global Mouth Ulcer Treatment Market Outlook, By Drug Class (2021-2030) ($MN)
• Table 8 Global Mouth Ulcer Treatment Market Outlook, By Antimicrobial (2021-2030) ($MN)
• Table 9 Global Mouth Ulcer Treatment Market Outlook, By Antihistamine (2021-2030) ($MN)
• Table 10 Global Mouth Ulcer Treatment Market Outlook, By Analgesics (2021-2030) ($MN)
• Table 11 Global Mouth Ulcer Treatment Market Outlook, By Corticosteroids (2021-2030) ($MN)
• Table 12 Global Mouth Ulcer Treatment Market Outlook, By Other Drug Classes (2021-2030) ($MN)
• Table 13 Global Mouth Ulcer Treatment Market Outlook, By Formulation (2021-2030) ($MN)
• Table 14 Global Mouth Ulcer Treatment Market Outlook, By Sprays (2021-2030) ($MN)
• Table 15 Global Mouth Ulcer Treatment Market Outlook, By Mouthwash (2021-2030) ($MN)
• Table 16 Global Mouth Ulcer Treatment Market Outlook, By Gels (2021-2030) ($MN)
• Table 17 Global Mouth Ulcer Treatment Market Outlook, By Lozenges (2021-2030) ($MN)
• Table 18 Global Mouth Ulcer Treatment Market Outlook, By Other Formulations (2021-2030) ($MN)
• Table 19 Global Mouth Ulcer Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 20 Global Mouth Ulcer Treatment Market Outlook, By Aphthous Stomatitis (2021-2030) ($MN)
• Table 21 Global Mouth Ulcer Treatment Market Outlook, By Oral Lichen Planus (2021-2030) ($MN)
• Table 22 Global Mouth Ulcer Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 23 Global Mouth Ulcer Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
• Table 24 Global Mouth Ulcer Treatment Market Outlook, By Oral (2021-2030) ($MN)
• Table 25 Global Mouth Ulcer Treatment Market Outlook, By Topical (2021-2030) ($MN)
• Table 26 Global Mouth Ulcer Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 27 Global Mouth Ulcer Treatment Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 28 Global Mouth Ulcer Treatment Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 29 Global Mouth Ulcer Treatment Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 30 Global Mouth Ulcer Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 31 Global Mouth Ulcer Treatment Market Outlook, By Homecare (2021-2030) ($MN)
• Table 32 Global Mouth Ulcer Treatment Market Outlook, By Clinic (2021-2030) ($MN)
• Table 33 Global Mouth Ulcer Treatment Market Outlook, By Hospital (2021-2030) ($MN)
• Table 34 Global Mouth Ulcer Treatment Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.